Valsartan 160mg

DRUG3 trials

Sponsors

LG Life Sciences, Vanderbilt University, Ohio State University

Conditions

Blood PressureHyperlipidemiaHypertension,Impaired Glucose ToleranceObesityPreDiabetesType 2 Diabetes Mellitus

Phase 3

Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia

CompletedNCT01918332

LG Life SciencesHyperlipidemia, Hypertension,

Start: 2012-04-30End: 2013-03-31Updated: 2014-12-15

Phase 4

Effect of DPP4 Inhibition on Vasoconstriction

CompletedNCT02639637

Vanderbilt UniversityType 2 Diabetes Mellitus

Start: 2015-12-31End: 2017-09-30Updated: 2018-08-27

The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans

Active, not recruitingNCT03938389

Ohio State UniversityBlood Pressure, Impaired Glucose Tolerance, Obesity +1

Start: 2020-02-25End: 2026-06-30Target: 90Updated: 2025-08-11